Literature DB >> 9562009

Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine.

R Yamakawa1, M Ishii, T Sugimura, T Akagi, G Eto, M Iemura, T Tsutsumi, H Kato.   

Abstract

OBJECTIVES: This study sought to assess the endothelial function of long-term coronary artery lesions in patients with Kawasaki disease (KD).
BACKGROUND: The vascular function of the coronary arteries in children with long-term KD remains uncertain. We report our findings of the vascular response of the coronary arteries to intracoronary injection of acetylcholine (ACh) in patients with KD.
METHODS: A total of 35 patients (25 patients with KD and 10 control subjects) were examined using coronary angiography. Individual arteries were divided into four groups according to the type of the coronary artery lesion: group 1 consisted of 25 sites with regressed aneurysms. These aneurysms had developed in the acute stage but had subsequently regressed and demonstrated normal findings on the follow-up coronary angiogram. Group 2 consisted of 24 sites with persistent aneurysms. Group 3 involved 60 angiographically normal sites in the same patients as those in group 1 or 2. Group 4 consisted of 30 sites in control subjects who had congenital heart disease with normal coronary arteries. During coronary angiography we infused 15 microg of ACh chloride into the coronary artery. The lumen diameters were measured using a cine videodensitometric analyzer to study the distensibility of the coronary artery wall.
RESULTS: The mean (+/-SD) change in diameter was an increase of 11.71+/-12.34% in group 3 (coronary arteries without lesions in patients with KD) and 12.21+/-9.71% in the control group, demonstrating marked vasodilation in both groups. In contrast, the changes in the regressed aneurysms of group 1 and in the persistent aneurysms of group 2 were -2.65+/-12.12% and -0.08+/-6.51%, respectively, demonstrating no change or mild vasoconstriction. The change in groups 1 and 2 was significantly less than that in group 3 or in the control group. Group 3 showed no significant difference from the control group.
CONCLUSIONS: These findings suggest that long-term coronary artery lesions, even after aneurysm regression, may have impaired endothelial function. A long-term follow-up study for those patients is essential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562009     DOI: 10.1016/s0735-1097(98)00033-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.

Authors:  Ming He; Zhen Chen; Marcy Martin; Jin Zhang; Panjamaporn Sangwung; Brian Woo; Adriana H Tremoulet; Chisato Shimizu; Mukesh K Jain; Jane C Burns; John Y-J Shyy
Journal:  Circ Res       Date:  2016-12-06       Impact factor: 17.367

3.  Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease.

Authors:  Silvana Cicala; Teresa Pellegrino; Giovanni Storto; Maria Grazia Caprio; Rodolfo Paladini; Ciro Mainolfi; Francesco de Leva; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-03       Impact factor: 9.236

Review 4.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease.

Authors:  Y Ikemoto; H Ogino; M Teraguchi; Y Kobayashi
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

6.  The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.

Authors:  Ariane McNeal-Davidson; Anne Fournier; Rosie Scuccimarri; Adrian Dancea; Christine Houde; Marc Bellavance; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2012-06-17       Impact factor: 1.655

Review 7.  Interventions in Kawasaki disease.

Authors:  T Akagi
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

Review 8.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

9.  Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndrome.

Authors:  Gregory H Kurio; Katrine A Zhiroff; Lily J Jih; Arnost S Fronek; Jane C Burns
Journal:  Pediatr Cardiol       Date:  2007-09-21       Impact factor: 1.655

10.  High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.

Authors:  Yung-Chuan Chen; Ching-Tsuen Shen; Nan-Koong Wang; Yi-Ling Huang; Hsin-Hui Chiu; Chun-An Chen; Shuenn-Nan Chiu; Ming-Tai Lin; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.